Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 9.17% is 15% above its 5-year average of 7.99%, near the high end of its 5-year range (7.00%–9.17%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.10% above its 12-month average of 8.64%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 9.17%.
RETURN ON EQUITY (ROE)
9.17%
RETURN ON EQUITY (ROE) AVG TTM
8.64%
RETURN ON EQUITY (ROE) AVG 3Y
8.34%
RETURN ON EQUITY (ROE) AVG 5Y
7.99%
RETURN ON EQUITY (ROE) AVG 10Y
7.48%
RETURN ON EQUITY (ROE) AVG 15Y
7.73%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.10%
CURRENT VS 3Y AVG
+9.99%
CURRENT VS 5Y AVG
+14.81%
CURRENT VS 10Y AVG
+22.61%
CURRENT VS 15Y AVG
+18.72%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.25%
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+123.98%
vs the sector median at left
Addus HomeCare Corporation
Market Cap
$2.11B
Return on Equity (ROE)
9.17%
TTM Avg
8.64%
3Y Avg
8.34%
5Y Avg
7.99%
Market Cap
$2.06B
Return on Equity (ROE)
N/A
TTM Avg
-101.38%
3Y Avg
-17.29%
5Y Avg
175.33%
Market Cap
$2.17B
Return on Equity (ROE)
-42.07%
TTM Avg
-35.11%
3Y Avg
-34.40%
5Y Avg
-30.49%
Market Cap
$2.05B
Return on Equity (ROE)
16.36%
TTM Avg
13.19%
3Y Avg
3.41%
5Y Avg
-4.94%
Market Cap
$2.02B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$2.02B
Return on Equity (ROE)
51.09%
TTM Avg
25.46%
3Y Avg
0.90%
5Y Avg
-9.89%
Market Cap
$2.01B
Return on Equity (ROE)
-16.25%
TTM Avg
-99.56%
3Y Avg
-48.75%
5Y Avg
-32.00%
Market Cap
$2.00B
Return on Equity (ROE)
-13.09%
TTM Avg
-10.89%
3Y Avg
-18.29%
5Y Avg
-19.41%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Addus HomeCare Corporation (ADUS) | $2.11B | 9.17% | 8.64% | 8.34% | 7.99% |
| Alvotech (ALVO)vs › | $2.07B | N/A | 23.18% | 49.13% | 48.50% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | N/A | -101.38% | -17.29% | 175.33% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -42.07% | -35.11% | -34.40% | -30.49% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 16.36% | 13.19% | 3.41% | -4.94% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -48.43% | -97.59% | -126.46% | -100.04% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 51.09% | 25.46% | 0.90% | -9.89% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -16.25% | -99.56% | -48.75% | -32.00% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.09% | -10.89% | -18.29% | -19.41% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -8.14% | -6.28% | -6.47% | -2.03% |
ROE
9.2%
ROA
7.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 9.17% |
| 2026-03-31 | 8.94% |
| 2025-12-31 | 8.84% |
| 2025-09-30 | 8.16% |
| 2025-06-30 | 8.12% |
| 2025-03-31 | 7.94% |
| 2024-12-31 | 7.58% |
| 2024-09-30 | 7.77% |
| 2024-06-30 | 7.48% |
| 2024-03-31 | 9.06% |
| 2023-12-31 | 8.85% |
| 2023-09-30 | 8.43% |
| 2023-06-30 | 8.08% |
| 2023-03-31 | 7.74% |
| 2022-12-31 | 7.26% |
| 2022-09-30 | 7.21% |
| 2022-06-30 | 7.40% |
| 2022-03-31 | 7.63% |
| 2021-12-31 | 7.86% |
| 2021-09-30 | 7.26% |
| 2021-06-30 | 7.00% |
| 2021-03-31 | 6.30% |
| 2020-12-31 | 6.39% |
| 2020-09-30 | 6.83% |
| 2020-06-30 | 6.15% |
| 2020-03-31 | 5.96% |
| 2019-12-31 | 5.31% |
| 2019-09-30 | 4.27% |
| 2019-06-30 | 6.47% |
| 2019-03-31 | 6.22% |
| 2018-12-31 | 6.35% |
| 2018-09-30 | 5.95% |
| 2018-06-30 | 8.48% |
| 2018-03-31 | 7.86% |
| 2017-12-31 | 7.77% |
| 2017-09-30 | 10.41% |
| 2017-06-30 | 9.65% |
| 2017-03-31 | 9.80% |
| 2016-12-31 | 7.57% |
| 2016-09-30 | 5.17% |
| 2016-06-30 | 6.04% |
| 2016-03-31 | 6.75% |
| 2015-12-31 | 8.20% |
| 2015-09-30 | 8.88% |
| 2015-06-30 | 9.35% |
| 2015-03-31 | 10.56% |
| 2014-12-31 | 10.93% |
| 2014-09-30 | 8.90% |
| 2014-06-30 | 8.60% |
| 2014-03-31 | 7.07% |
| 2013-12-31 | 16.82% |
| 2013-09-30 | 19.50% |
| 2013-06-30 | 19.26% |
| 2013-03-31 | 18.80% |
| 2012-12-31 | 8.09% |
| 2012-09-30 | 9.68% |
| 2012-06-30 | -2.34% |
| 2012-03-31 | -2.53% |
| 2011-12-31 | -2.29% |
| 2011-09-30 | -6.54% |
| 2011-06-30 | 5.75% |
| 2011-03-31 | 6.21% |
| 2010-12-31 | 6.84% |
| 2010-09-30 | 3.13% |
| 2010-06-30 | 3.96% |
| 2010-03-31 | 4.38% |
| 2009-12-31 | 4.47% |
| 2009-09-30 | 17.64% |
| 2009-06-30 | 15.95% |
